𩺠å
§ç§å°ç§èåç
1ïžâ£ Rabies PEP After Travel Returning
- Bite history in endemic country (esp Asia/Africa)
- Even if delayed â give PEP (no time limit; PEP effective even if started weeks after exposure as long as not yet symptomatic)
- HRIG + 4-dose vaccine schedule
- Public Health notification + investigation
2ïžâ£ Imported Rabies USA
- 1-3 deaths/yr typically
- Often imported from Asia/Africa (delayed presentation)
- 2024 cases reported in returning travelers
- æé medicine: thorough exposure history
3ïžâ£ PEP Time Sensitivity
- Sooner the better â but no absolute time limit before symptoms
- Best if started within days of exposure
- Effective even if started weeks-months later (as long as no symptoms)
- Donât deny PEP based on delay alone
4ïžâ£ Milwaukee Protocol Controversy
- Originally hopeful (Jeanna Giese 2004 survivor)
- ~ 30 attempts, ~ 5 documented survivors
- 2024: meta-analysis suggests no clear benefit over standard supportive care
- Some experts now disfavor specific protocol
- Cases evaluated individually with ID/critical care consultation
5ïžâ£ Organ Transplant Rabies
- 2004 USA: 4 recipients of organs from donor with undiagnosed rabies â all died
- Donor screening (history) but no universal lab test
- Rare but well-documented
- Highlights importance of clinical screening + atypical fever workup in donors
7ïžâ£ Pediatric Bites
- Children more likely:
- Closer to ground (animal head proximity)
- Bites on face/scalp (rapid PEP critical)
- Less likely to report exposure
- High suspicion + lower threshold for PEP
8ïžâ£ å¥ä¿ / Taiwan
- éå ± mandatory
- Taiwan: 2013 outbreak in ferret-badgers (Melogale moschata) â first wild rabies in 50+ yr
- Vaccination of farm animals + pets
- å
¬è²» PEP for exposed
- å
¬è²» PrEP limited (high-risk groups)
- ç§é«åž« hint: åç©å¬å· + äžæ vaccination â ç«å³ PEP + ID consult
9ïžâ£ WHO 2030 Goal
- End dog-mediated rabies deaths by 2030
- Mass dog vaccination
- Improved PEP access
- Surveillance + community engagement
- One Health approach (human + animal + environment)
10. Future + Newer Vaccines
- mRNA rabies vaccine (Moderna mRNA-1944) â in development
- Simplified schedules
- Single-dose post-exposure vaccines researched
- Improved access for LMICs
- Cost-effectiveness analyses for global rollout